Wednesday, October 21, 2026
Saga
Heidi Overton FDA confirmation scrutiny
Overview
Description Heidi Overton’s FDA commissioner nomination is under Senate scrutiny over vaccine safety, drug policy, reproductive health questions, and independence. Overview Senators questioned Heidi Overton during a September 24 confirmation hearing for FDA commissioner. Overton broke with President Trump on measles vaccine safety…
Keeping an eye on this saga?
Tilt can alert you when its scenarios shift, or send you a recommendation when one crosses a threshold.
Stories in this saga
1 story, 2 sources
Sep 24, 2026
FDA Nominee Overton Contradicts Trump on Vaccine Safety
- FDA Nominee Heidi Overton Contradicts Trump on Measles Vaccine Safety27 days ago